4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-024608
INTERIM PRESIDENT AND CEO gave up 2,722 shares (to pay taxes)
- INTERIM PRESIDENT AND CEO acquired 9,467 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-10-01 | Option exercise | +9,467 | 1,372,364 | D | ||
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-10-01 | Shares withheld for taxes | −2,722 | $1.18 | $3,212 | 1,369,642 | D |
| Derivatives | |||||||
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-10-01 | Option exercise · Restricted Stock Units | −9,467 | 66,267 | D | ||
Loading xslF345X05/form4-10032024_041004.xml…